Fostair now for maintenance and reliever therapy in asthma

Fostair (formoterol/beclometasone) can now be prescribed for patients with asthma who require maintenance and reliever therapy (MART).

Fostair delivers beclometasone as extra-fine particles so doses delivered are not bioequivalent to most other beclometasone inhaler formulations.
Fostair delivers beclometasone as extra-fine particles so doses delivered are not bioequivalent to most other beclometasone inhaler formulations.

MART should especially be considered for patients with uncontrolled asthma or with past exacerbations that have required medical attention. The recommended dosing regimen for Fostair in MART is one puff twice daily, with 1–2 additional puffs as needed up to a maximum of 8 puffs daily.

Evidence to support this regimen was provided by a 48-week parallel group study in 1701 patients with uncontrolled moderate to severe asthma. Patients were treated with the MART regimen or the standard maintenance regimen for Fostair (one puff twice daily plus concomitant salbutamol used as required). 

The MART regimen significantly prolonged the time to first severe exacerbation and the rate of severe exacerbations compared with the standard regimen (p<0.001 for both). Patients receiving MART also achieved a clinically meaningful improvement in asthma control.

View Fostair drug record
    
Further information: Chiesi Ltd

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Fostair NEXThaler: extrafine dry powder inhaler launched for asthma

Fostair NEXThaler: extrafine dry powder inhaler launched for asthma

Fostair NEXThaler (formoterol/beclometasone) is the...

New COPD licence for Fostair

New COPD licence for Fostair

Fostair (formoterol/beclometasone) can now be prescribed...

Relvar Ellipta: combination inhaler for asthma and COPD

Relvar Ellipta: combination inhaler for asthma and COPD

Relvar Ellipta (vilanterol/fluticasone furoate) is...

Flo-Tone MDI: inhaler training device

Flo-Tone MDI: inhaler training device

Clement Clarke has launched Flo-Tone MDI, a dual spacer...

Flutiform: novel asthma combination inhaler

Flutiform: novel asthma combination inhaler

Flutiform (formoterol fumarate/fluticasone propionate)...



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more